EUVIMEDEUVIMED entdecken
Crossref

Solvent-Free Fabrication Of Tacrolimus-Loaded Solid Lipid Nanoparticles Via Continuous Hot-Melt Extrusion: Process Optimization And Characterization

Sushama Sagar Pole, Dr. Rajani B. Athawale, Dr. Mullaicharam Bhupathyraaj

International Journal of Drug Delivery Technology · 11.05.2026 · 16 (26s)

DOI: 10.25258/ijddt.16.26s.84 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.05.2026. Verfasst von Sushama Sagar Pole und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The present study is aimed to develop and evaluate tacrolimus-loaded solid lipid nanoparticles (slns) using stearic acid (hs8) and hydrogenated castor oil (hc5) to enhance solubility, stability, and controlled drug release, addressing the limitations of tacrolimus such as poor aqueous solubility, low oral bioavailability and a narrow therapeutic window.

Objectives

To prepare tacrolimus-loaded slns using hot melt extrusion (hme) followed by lyophilization. To compare the effects of stearic acid and hydrogenated castor oil on particle characteristics, drug encapsulation and release profiles. Methodology: Slns were prepared by hot melt extrusion, followed by high-pressure homogenization and lyophilization with mannitol as a cryoprotectant. Optimization was performed using a box-behnken design to study the effects of lipid, surfactant, co-surfactant and screw speed on particle size, zeta potential and entrapment efficiency. Formulations were characterized for particle size, pdi, zeta potential, drug content, entrapment efficiency, percentage yield, ftir, dsc, xrd, sem and in-vitro drug release in fasted state simulated intestinal fluid (fassif) and fed state simulated intestinal fluid (fessif). Results and Discussion: Optimized formulations hs8 and hc5 showed nanosized particles (19–60 nm for hs8; 59– 198 nm for hc5), high entrapment efficiency (94.5% and 93.6%) and drug content (97.2% and 96.8%). Hs8 exhibited smaller particle size, higher negative zeta potential and slightly better colloidal stability than hc5. Drug release studies revealed sustained, diffusion-controlled release following the higuchi model, with hs8 and hc5 outperforming the marketed formulation in both fasted and fed-state conditions. Ftir confirmed compatibility, while dsc and xrd indicated partial amorphization, enhancing solubility and dispersion. Sem showed well-formed, spherical nanoparticles for hs8 and irregular but dispersed particles for hc5.

Conclusion

Hs8 and hc5 slns demonstrated improved solubility, sustained drug release and potential for enhanced intestinal absorption, making them promising carriers for effective tacrolimus delivery. Stearic acid-based slns showed slightly superior performance in terms of particle size, stability, and yield.

Zitieren

APA

Pole, S. S., Athawale, D. R. B., & Bhupathyraaj, D. M. (2026). Solvent-Free Fabrication Of Tacrolimus-Loaded Solid Lipid Nanoparticles Via Continuous Hot-Melt Extrusion: Process Optimization And Characterization. International Journal of Drug Delivery Technology, 16(26s). https://doi.org/10.25258/ijddt.16.26s.84

Vancouver

Pole SS, Athawale DRB, Bhupathyraaj DM. Solvent-Free Fabrication Of Tacrolimus-Loaded Solid Lipid Nanoparticles Via Continuous Hot-Melt Extrusion: Process Optimization And Characterization. International Journal of Drug Delivery Technology. 2026;16(26s). doi:10.25258/ijddt.16.26s.84

BibTeX
@article{Pole2026,
  author = {Pole, Sushama Sagar and Athawale, Dr. Rajani B. and Bhupathyraaj, Dr. Mullaicharam},
  title = {Solvent-Free Fabrication Of Tacrolimus-Loaded Solid Lipid Nanoparticles Via Continuous Hot-Melt Extrusion: Process Optimization And Characterization},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {26s},
  doi = {10.25258/ijddt.16.26s.84}
}
Kostenlos starten →